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1. Introduction 
Mycobactin is a lipid-soluble iron-binding compound, 
which is located in the mycobacterial cell envelope 
where it acts as a transporter of ferric ions across the 
thick lipoial boundary layers [ 11. The release of iron 
from its carrier is mediated by a ferri-reductase but 
assay of this activity was severely hampered by 
having to use very turbid cell extracts and also by 
the facility with which the ensuing ferrous ion 
reoxidized and then recombined with mycobactin 
[l] . Very little could therefore be learnt about the 
enzyme. In this paper we describe an improved 
method for determining its activity, which may have 
a general applicability to other microbial iron trans- 
port systems, and are now able to describe some of 
its properties. 
2. Methods 
2.1. Growth of organism and preparation of cell 
extracts 
I%! smegmatis NCIB 8548 was grown on iron- 
deficient medium as previously described [ 1,2] . 
Cells were washed with distilled water after harvesting 
and mixed with a little 0.1 M Tris-HCl, pH 7.0, 
buffer before disrupting by a single passage through 
a Hughes’ press or French pressure chamber at 
3.5 X lo4 knmp2. Disrupted material was diluted 
* Present address: Chemical Defence Establishment, 
Porton Down, Salisbury, Wilts., U.K. 
262 
as required using 0.1 M Tris-HCl buffer and gently 
homogenized in an all-glass homogenizer. 
2.2. Assay of ferrimycobactin reductase 
Two assay methods were developed both relying 
upon changes in extinction at 450 nm, i.e. the 
absorption maximum of ferrimycobactin. 
Method 1. This method was developed for assay of 
the enzyme activity in extremely dense (Edso > 15) 
uncentrifuged cell extracts. Ferrimycobactin was 
generated in+situ by adding Fe(salicylate)a , at about 
0.25 mM final concentration, to the extract which 
being from iron-deficient cells contained mycobactin, 
and then holding at 37°C for about 10 min. The 
assay mixture in Thunberg tubes contained, in a 
final vol of 3 ml, cell extract, 2.8 ml; EDTA 10 pmol, 
and NAD(P)H, 10 pmol, in the sidearm. The 
Thunberg tubes were closed, repeatedly evacuated and 
flushed with N2 (0, free; see below) before sealing 
under a slight positive pressure of N2. Tubes were 
equilibrated for 10 min before starting the reaction 
by tipping in the NAD(P)H. After incubation, the 
extinctions of the solutions were read at 450 nm 
using a Cary 14 UV recording spectrophotometer 
fitted with a scattered transmission accessory and 
high intensity light source. As reference, an 
incubation mixture which had lacked NAD(P)H 
was used. 
Method 2. After establishing the validity of Method 
1 and the suitability of EDTA as a chelator of Fe(B) 
(see Results), routine assays of ferrimycobactin reduc- 
tase were conduced using cell-extracts, centrifuged at 
30 000 g for 30 min at 2°C and incubated in anaerobic 
glass cuvettes each fitted with a sidearm. The assay 
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mixture in a final vol of 3 ml, contained cell-extract 
up to 2.7 ml; EDTA 10 pmol; ferrimycobactin S 680 
nmol in 1% Triton Nl 01 (0.2 ml) and, placed in the 
sidearm, NAD(P)H up to 10 pmol. N2 (0, free) was 
blown across the surface of the contents of the cuvette 
for 5 min. The cuvette was then equilibrated at 37°C for 
10 min and the reaction started by tipping the 
NAD(P)H. The change in E4so was followed 
against a reference cuvette lacking NAD(P)H. 
2.3. Beparation of 02-free nitrogen 
Commercial Oz-free Nz was bubbled through 
a de-oxygenator containing 2% (w/v) Naz SZ 04 
in 0.2 M Naz HP04 and then through two Dreschel 
bottles containing 2 M NaOH to remove any traces of 
Naz SZ 04. 
3. Results 
3.1. Requirement for an Fe(‘I) chelator for assay of 
ferrimycobactin reductase 
The original assay of ferrimycobactin reductase 
[ 1,3] involved the direct spectrophotometric 
measurement of changes in the concentration of 
ferrimycobactin but considerable difficulty was 
experienced in achieving reproducible assays due to 
the very dense solutions which had to be used and 
also to the rapidity with which the Fe(I1) was re-oxi- 
dized to Fe(I1*) which then recombined spontaneously 
with the free mycobactin. Some chelator of iron was 
needed which would prevent either this re-oxidation 
or the subsequent recombination of Fe(III) with 
mycobactin. 
To find a suitable chelator, ferrimycobactin 
(0.2 mM) was reduced non-enzymatically using 
Naz S2 O4 under anaerobic conditions in the presence 
of a variety of chelating agents, each at 0.66 mM. The 
procedure followed was similar to that given in 
fig. 1. Of the chelators tried, EDTA appeared the 
most suitable as the resulting mixture was almost 
colouriess. o-Phenanthroline and 2,2’-dipyridyl did 
form complexes with the iron which was released 
but had high extinctions around 450 nm and therefore 
could not be distinguished from ferrimycobactin. 
Nitrilotriacetic acid was ineffective in this system. In 
the absence of Naz SZ 04, but still under N, , EDTA 
did not remove iron from ferrimycobactin during 
6 hr incubation. The efficacy of EDTA is due to the 
formation of a colourless Fe(I1) chelate which, when 
the reaction is complete and air re-introduced into 
the tubes, is rapidly re-oxidized to a pale yellow 
Fe(III) chelate [4] with E = 6.0-6.5 at 450-470 nm 
(C. Ratledge, unpublished) whereas that of ferri- 
mycobactin at this wavelength is 3780 [ 51. Thus, 
as iron is not readily transferred from EDTA into 
mycobactin, the concentration of ferrimycobactin 
can be determined even in the presence of excess 
ferri EDTA (fig. 1). 
When EDTA was incorporated into an assay for 
ferrimycobactin reductase (Method l), it produced 
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Fig.1. Spectra of ferrimycobactin S in the presence of EDTA 
before (line 1) and after (line 2) reduction with Na, S, 0, 
under N, and subsequent re-oxidation. EDTA was at 3.3 mM 
and ferrimycobactin at 0.2 mM and was dissolved in 0.09 M 
Tris buffer, pH 7.5, containing 1% Tween 80. For reduction 
the components were held in a Thunberg tube and flushed 
with N,. Na, S, 0, (approx. 1 mg) was tipped in from the 
side-arm and after 5 min the tube opened, air blown in for 
15 min and the spectra then determined. 
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Table 1 3.2. Some properties of fem’mycobactin reductase 
Reduction of ferrimycobactin formed in situ in an 
uncentrifuged extract of iron-deficiently grown 
M. smegmatis 
Additions to extract 
+ ferrimycobactin in 
assay system 
Ferrimycobactin 
reduced 
(nmol) 
Preliminary work [l] indicated that ferrimyco- 
bactin reductase was a particulate enzyme, but upon 
using the improved assay for the enzyme, between 
70 and 80% of the total amount of enzyme present 
remained in solution after centrifuging the disrupted 
cells (table 2). Even centrifuging at 150 000 g 
failed to sediment it. Thus, the direct attachment of 
the enzyme to a membrane is doubtful. This result 
meant that subsequent assays of the enzyme could 
be carried out on centrifuged cell extracts. 
None 55 
NADH 74 
NADPH 76 
EDTA 176 
NADH + EDTA 682 
NADPH + EDTA 680 
Cell extract, 2.8 ml, 15.0 mg protein/ml, containing ferri- 
mycobactin was incubated at 30°C for 4.5 hr under anae- 
robic conditions as given in Methods (assay Method 1). 
NAD(P)H and EDTA were each at 10 nmol. 
a 9-fold increase in activity (table 1). In the absence 
of cell extract ferrimycobactin was not reduced even 
in the presence of a high concentration of NADH 
(20 mg). A boiled cell extract had no reactivity in the 
complete assay system. 
Adding EDTA, in the absence of NAD(P)H, 
tripled the amount of ferrimycobactin reduced 
(table 1) probably due to endogenous reductants 
within the cell extracts. The high control value of 
5.5 nmol ferrimycobactin reduced in the period 
of assay is probably due to the same reason. There 
was no increase in the-&c activity of the enzyme 
when cell extracts were prepared in buffer containing 
either 1 mM dithiothreitol or 1 mM mercaptoethanol. 
The stringent requirement for anaerobicity during 
assay of the enzyme was shown by gassing the assay 
mixture with N2 for various times (fig.2). Traces of 
oxygen are tolerated by the enzyme as there was no 
difference in the rate of reaction when it was gassed 
for different times; but all oxygen had to be consumed 
(by endogenous respiratory processes) before activity 
of ferrimycobactin reductase was manifested. 
Ferrimycobactin reductase was rapidly inactivated 
when held at temperatures over 37°C. At 45’C, 50% 
inactivation occurred in 10 min and at 80°C 90% 
inactivation occurred in the same time; the enzyme 
was completely inactivated by holding at 100°C for 
10 min. At 37°C for 10 min, however, the enzyme 
was just as stable as a preparation held at O’C for the 
same time. The stability of the enzyme was such 
that it could be stored at 4°C for up to 4 days with- 
out loss of activity. 
The enzyme had a sharp optimum activity at 
pH 7.0 (fig.3). It had only 40% of this activity at 
pH 7.4 and 75% of this activity at pH 6.5. 
Uncentrifuged cell extracts had shown little 
Table 2 
Distribution of ferrimycobactin reductase in cell fractions 
Cell fraction Specific activity 
(nmol ferrimycobactin) 
reduced/30 min/mg protein) 
Total activity in 
fraction (nmol ferri- 
mycobactin reduced/30 min) 
Whole cell extract 26 9880 (100%) 
Pellet after initial centrifuging* 16 1760 (18%) 
Supernatant 27 7020 (71%) 
Supernatant after re-centrifuging** 26 6052 (61%) 
Enzyme activity determined as given in Methods (assay Method 1). 
* 30,000 g at 2°C for 30 min. 
** 150,OOOg at 2°C for 30 min. 
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Fig.3. pH profile of ferrimycobactin reauctase. Enzyme 
assayed as given in Methods (assay Method 2). Enzyme 
prepared in 10 mM Tri-HCl buffer pH 7.5 and 1.0 ml 
added to 1.6 ml 100 mM Bis-Tris-HCl of various pH 
values. 
20 30 40 50 
TIME (min) 
60 
Fig.2. Effect of time of gassing with N, on activity of 
ferrimycobactin reductase. Enzyme assayed as given in 
Methods (assay Method 2) with gassing for 5 min 
(line l), 2 min (line 2), 1 min (line 3) and without gassing, 
aerobic, (line 4). 
preference between NADH and NAD(P)H as 
electrons donors for the enzyme (see table 1) and 
using centrifuged extracts, in the assay Method 2, 
NAD(P)H was, in fact, 80% as effective as NADH 
(each at 3.3 mM) as cofactor for the reduction of 
ferrimycobactin. However, utilization of NADPH 
may not have been direct as the crude extracts may 
well have contained an active NAD(P)+ transhydro- 
genase serving to generate NADH in situ FADHs 
(FAD + sodium succinate each at 3.3 mM) though 
had 25% of the effectiveness of NADH as reductant. 
The specificity of the enzyme would therefore 
appear to be confined to NADH and NADPH. 
3.3. Effect of inhibitors on enzyme activity 
Strong inhibitors of the enzyme’s activity 
(followed by Method 2) were the sulphydryl reagents, 
p-chloromercuribenzoate and iodoacetate, each 
producing about 75% inhibition when present at 
1 mM. Sodium amytal, being an inhibitor of NADH 
oxidation [6], was tested also at 1 mM and inhibited 
activity by 80%. Triton, used routinely in the assay 
at 0.066% (w/v) as a solubilizer for mycobactin, 
inhibited activity by 30% only when added at 10 
times this concentration. p-Aminosalicyclic acid 
(PAS) was tested against the enzyme as other work 
[7] has shown this compound to be a probable 
inhibitor of iron assimilation but even at 1 mM it 
was ineffective. Salicylate, which appears to have 
some role in iron transport [8] and for which PAS 
is probably antimetabolite, also had no effect when 
at 1 mM on the activity of the reductase. 
4. Discussion 
Although a wide variety of iron ionophores are 
now recognized in microbial systems [9- 151 there 
has not been much work done on the mechanism by 
which iron is released from them. O’Brien et al. [ 141 
described the properties of an esterase from E. coli 
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which hydrolysed enterochelin whilst still co-ordinated 
with Fe(lrI). This allowed the iron to become 
available to the cell presumably by subsequent 
reduction and insertion into porphyrins via ferro- 
chelatase [ 16,171, Bryce and Brot [ 181, however, 
failed to find this esterase which is somewhat discon- 
certing for the presentation of a unified view of iron 
transport in this bacterium. 
In Ustilagu sphaerogenes a NAD(P)H ferri-ferri- 
chrome reductase, presumably similar to the enzyme 
reported here from M. smegmatis, was found by H. 
Komai and reported by Neilands [lo] . But apart 
from this report, there have been no other reports 
of the existence of similar enzymes in micro-organisms 
but it would not be surprising to find that reduction 
of the iron was a widely used method for removing 
iron from its carrier. Reduction is not only energetically 
economic but, as most carriers have little affinity 
for Fe(II), the iron can then be easily removed. 
Provided no re-oxidation of Fe(II) occurs, it is then 
in a suitable state for immediate insertion into 
porphyrins and other acceptor molecules. The 
carrier, being unchanged by the action of the 
reductase, is free to return to the outside of the cell 
envelope to recommence the transport process. The 
systematic name for this enzyme from M. smegmatis 
is NAD(P)H: ferrimycobactin oxidoreductase. 
Although some Fe(II) released from mycobactin 
will be incorporated into porphyrins or porphyrin- 
enzyme complexes, to give haem or haem-enzymes, 
most will be incorporated into non-haem iron proteins 
which probably constitute at least 90% of the total 
intracellular iron [ 19,201. Mechanisms for insertion 
of iron into both these materials have yet to be 
elucidated in the mycobacteria but they may not 
necessarily be associated with the membranes of 
the cell. Km-up and Brodie [20] found that 65% 
of the total iron within M. phlei was recovered in the 
soluble cell-free extract rather than in sedimented 
particles and thus our finding that 70% of the total 
amount of ferrimycobactin reductase could be 
recovered in the soluble fraction may be in accord 
with their results. 
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